Cell Biologics, Inc.

CHICAGO, IL 60612

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.87MM
First Award Date 09/15/14
Most Recent Award Date 09/15/17

Key Personnel

Last Name Name Awards Contact
BACHMAIER KURT BACHMAIER 1
MALIK ASRAR B. MALIK 4
KANTETI PRASAD V. S. KANTETI 1

4 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 09/15/17 - 06/30/18

ABSTRACT Sepsis-induced ALI/ARDS is a devastating syndrome of acute respiratory failure in critically ill patients that accounts for among the highest admission rates in ICU and mortality. During STTR Phase I, we at Cell Biologics Inc., demonstrated that piceatannol, a naturally occurring anti-inflammatory that selectively inhibits Syk tyrosine ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-14-072
Budget: 12/01/15 - 11/30/16

? DESCRIPTION (provided by applicant): Severe infections, various types of trauma, and other etiologic factors can cause ALI that rapidly morphs into ARDS. The incidence of ALI/ARDS is around 190,000 in adults in US alone. Despite medical advances and better management through ventilation-intervention, the mortality is still unacceptably high...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-14-072
Budget: 12/01/14 - 11/30/15

DESCRIPTION (provided by applicant): Severe infections, various types of trauma, and other etiologic factors can cause ALI that rapidly morphs into ARDS. The incidence of ALI/ARDS is around 190,000 in adults in US alone. Despite medical advances and better management through ventilation-intervention, the mortality is still unacceptably high at 3...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-13-089
Budget: 09/15/14 - 08/31/15

Abstract Septicemia poses a major health care challenge. Modern therapies requiring suppression of patients'immune systems, a growing numbers of elderly people in the population, and the emergence of drug-resistant bacteria, have increased the prevalence and severity of the disease over the past few decades. Current treatments rely on drugs that...